Parathyroid Gland Hyperplasia in Renal Failure

  • Adriana S. Dusso
  • Mario Cozzolino
  • Eduardo Slatopolsky
Part of the Molecular Biology Intelligence Unit book series (MBIU)


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Parfitt AM. The hyperparathyroidism of chronic renal failure: A disorder of growth. Kidney Int 1997; 52:3–9.PubMedGoogle Scholar
  2. 2.
    Slatopolsky E, Finch J, Denda M et al. Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro. J Clin Invest 1996; 97:2534–2540.PubMedGoogle Scholar
  3. 3.
    Silver J, Bar Sela S, and Naveh-Many T. Regulation of parathyroid cell proliferation. Curr Op Nephrol Hyperten 1997; 6:321–326.Google Scholar
  4. 4.
    Gonzales EA, Martin KJ. Renal osteodystrophy: pathogenesis and management. Nephrol Dial Transplant 1995; 3:13–21.Google Scholar
  5. 5.
    Goodman WG, Goldin J, Kuizon BD et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 2000; 342:1478–1483.PubMedCrossRefGoogle Scholar
  6. 6.
    Cozzolino M, Dusso A, E. Slatopolsky. Role of calcium x phosphate product and bone-associated proteins on vascular calcification in renal failure. J Am Soc Nephrol 2001; 12:2511–2516.PubMedGoogle Scholar
  7. 7.
    Naveh-Many T, Rahaminow R, Livni N, and Silver J. Parathyroid cell proliferation in normal and chronic renal failure in rats: The effects of calcium, phosphate and vitamin D. J Clin Invest 1995; 96:1786–1793.PubMedGoogle Scholar
  8. 8.
    Kifor O, Moore FD, Wang P et al. Reduced immunostaining for the extracellular Ca sensing receptor in primary and uremic secondary hyperparathyroidism: J Clin Endocrinol Metab 1996; 81:1598–1606.PubMedCrossRefGoogle Scholar
  9. 9.
    Fukuda N, Tanaka H, Tominaga Y et al. Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients. J Clin Invest 1993; 92:1436–1443.PubMedGoogle Scholar
  10. 10.
    Slatopolsky E. The role of calcium, phosphorus and vitamin D metabolism in the development of secondary hyperparathyroidism. Nephrol Dial Transplant 1998; 13(S3):3–8.PubMedCrossRefGoogle Scholar
  11. 11.
    Silver J, Yalcindag C, Sela-Brown A et al. Regulation of the parathyroid hormone gene by vitamin D, calcium and phosphate. Kidney Int 1999; 73:S2–S8.CrossRefGoogle Scholar
  12. 12.
    Sela-Brown A, Silver J, Brewer G et al. Identification of AUF1 as a parathyroid hormone mRNA-3’-untranslated region-binding protein that determines parathyroid hormone mRNA stability. J Biol Chem 2000; 275:7424–7429.PubMedCrossRefGoogle Scholar
  13. 13.
    Denda M, Finch J, Slatopolsky E. Phosphorus accelerated the development of parathyroid hyperplasia and secondary hyperparathyroidism in rats with renal failure. Am J Kidney Dis 1996; 28:596–602.PubMedGoogle Scholar
  14. 14.
    Pestell RG Albanese C, Reutens AT et al. The cyclins and cyclin-dependent kinase inhibitors in hormonal regulation of proliferation and differentiation. Endocrine Reviews 1999; 20(4):501–534.PubMedCrossRefGoogle Scholar
  15. 15.
    Nasmyth K. Viewpoint: Putting the cell cycle in order. Science 1996; 274:1643–1645.PubMedCrossRefGoogle Scholar
  16. 16.
    Roberts JM, Koff A, Polyak K et al. Cyclins, cdks and cyclin kinase inhibitors. Cold Spring Harbor Symp on Quantitative Biology LIX 1994:31–38.Google Scholar
  17. 17.
    Zhang P, Duchambon P, Gogusev J et al. Apoptosis in parathyroid hyperplasia of patients with primary or secondary uremic hyperparathyroidism. Kidney Int 2000; 57:437–445.PubMedCrossRefGoogle Scholar
  18. 18.
    Jara A, Gonzalez S, Felsenfeld AJ et al. Failure of high doses of calcitriol and hypercalcaemia to induce apoptosis in hyperplastic parathyroid glands of azotaemic rats: Nephrol Dial Transplant 2001; 16:506–512.PubMedCrossRefGoogle Scholar
  19. 19.
    Canalejo A, Almaden Y, Torregrosa V et al. The in vitro effects of calcitriol on parathyroid cell proliferation and apoptosis: J Am Soc Nephrol 2000; 11:1865–1872.PubMedGoogle Scholar
  20. 20.
    Vasef MA, Brynes RK, Sturm M et al. Expression of cyclin D1 in parathyroid carcinomas, adenomas, and hyperplasia: a paraffin immunohistochemical study. Mod Pathol 1999; 12(4):412–416.PubMedGoogle Scholar
  21. 21.
    Imanishi Y, Hosokawa Y, Yoshimoto K et al. Primary hyperparathyroidism caused by parathyroid-targeted overexpression of cyclin D1 in transgenic mice: J Clin Ivest 2001; 107:1093–1101.Google Scholar
  22. 22.
    Tominaga Y, Tsuzuki T, Uchida K et al. Expression of Prad1/cyclin D1, retinoblastoma gene products, and Ki67 in parathyroid hyperplasia caused by chronic renal failure versus primary adenoma. Kidney Int 1999; 55:1375–1383.PubMedCrossRefGoogle Scholar
  23. 23.
    Erickson LA, Jin L, Thompson GB et al. Parathyroid hyperplasia, adenomas, and carcinomas: differential expression of p27Kip1 protein. Am J Surg Pathol 1999; 23(3):288–295.PubMedCrossRefGoogle Scholar
  24. 24.
    Brown AJ, Zhong M, Ritter C et al. Loss of calcium responsiveness in cultured bovine parathyroid cells is associated with decreased calcium receptor expression: Biochem Biophys Res Commun 1995; 212:861–867.PubMedCrossRefGoogle Scholar
  25. 25.
    Wang Q, Palnitkar S, Parfitt AM. Parathyroid cell proliferation in the rat. Effect of age, and of phosphate administration and recovery. Endocrinol 1996; 137:4558–4562.CrossRefGoogle Scholar
  26. 26.
    Wang Q, Palnitkar S, Parffitt AM. The basal rate of cell proliferation in normal human parathyroid tissue: implications for the pathogenesis of hyperparathyroidism. Clin Endocrinol 1997; 46:343–349.CrossRefGoogle Scholar
  27. 27.
    Dusso AS, Pavlopoulos T, Naumovich L et al. p21wafl and TGFa mediate dietary phosphate-regulation of parathyroid cell growth. Kidney Int 2001; 59:855–865.PubMedCrossRefGoogle Scholar
  28. 28.
    Portale AA, Halloran BP, Morris RC Jr. Physiologic regulation of serum concentration of 1,25-dihydroxyvitamin D by phosphorus in normal men. J Clin Invest 1989; 83:1494–1499.PubMedGoogle Scholar
  29. 29.
    Portale AA, Booth BE, Halloran BP et al. Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency. J Clin Invest 1984; 73:1580–1589.PubMedCrossRefGoogle Scholar
  30. 30.
    Liu M, Lee MH, Cohen M et al. Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937. Gene Develop 1996; 10:142–153.Google Scholar
  31. 31.
    DiCunto F, Topley G, Calautti E et al. Inhibitory function of p21Cip1/WAF1 in differentiation of primary mouse keratinocytes independent of cell cycle control. Science 1998; 280:1069–1072.CrossRefGoogle Scholar
  32. 32.
    Zhuang SH, Burnstein KL. Antiproliferative effect of 1alpha, 25-dihydroxyvitamin D3 in human prostate cancer cell line LNCaP involves reduction of cyclin-dependent kinase 2 activity and persistent G1 accumulation. Endocrinol 1998; 139:1197–1207.CrossRefGoogle Scholar
  33. 33.
    Ohtsubo M, Gamou S, Shimizu N. Antisense oligonucleotide of WAF1 gene prevents EGF-induced cell cycle arrest in A431 cells. Oncogene 1998; 16:797–802.PubMedCrossRefGoogle Scholar
  34. 34.
    Miyazaki M, Ohashi R, Tsuji T et al. Transforming growth factor-beta 1 stimulates or inhibits cell growth via down-or up-regulation of p21/Waf1. Biochem Biophys Res Com 1998; 246:873–880.PubMedCrossRefGoogle Scholar
  35. 35.
    Shankland SJ, Floege J, Thomas SE et al. Cyclin kinase inhibitors are increased during experimental membranous nephropathy: Potential role in limiting glomerular epithelial cell proliferation in vivo. Kidney Int 1997; 52:404–413.PubMedGoogle Scholar
  36. 36.
    Macleod KF, Sherry N, Hannon G et al. p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Gene Dev 1995; 9:935–944.PubMedGoogle Scholar
  37. 37.
    Bonfanti M, Taverna S, Salmona M et al. P21 WAF1-derived peptides linked to an internalization peptide inhibit human cancer cell growth. Cancer Res 1997; 57:1442–1446.PubMedGoogle Scholar
  38. 38.
    Yang ZY, Perkins ND, Ohno T et al. The p21 cyclin-dependent kinase inhibitor suppresses tumorigenicy in vivo. Nature Med 1995; 1:1052–1056.PubMedCrossRefGoogle Scholar
  39. 39.
    Gartel AL, Serfas MS, Tyner AL. p21-Negative regulator of the cell cycle. Proc Soc Exp Biol Med 1996; 213:138–149.PubMedGoogle Scholar
  40. 40.
    Kumar V, Bustiin SA, McKay IA. Transforming growth factor alpha. Cell Biol Int 1995; 19:373–388.PubMedCrossRefGoogle Scholar
  41. 41.
    Driman DK, Kobrin MS, Kudlow JE et al. Transforming growth factor-α in normal and neoplastic human endocrine tissues. Hum Pathol 1992; 23:1360–1365.PubMedCrossRefGoogle Scholar
  42. 42.
    Gogusev J, Duchambon P, Soermann-Chopard C et al. De novo expression of transforming growth factor-α in parathyroid gland tissue of patients with primary or secondary uraemic hyperparathyroidism. Nephrol Dial Transpl 1996; 11:2155–2162.Google Scholar
  43. 43.
    Wong ST, Winchell LF, McCune BK et al. The TGF-alpha precursor expressed on the cell surface binds to the EGF receptor on adjacent cells, leading to signal transduction. Cell 1989; 56:495–500.PubMedCrossRefGoogle Scholar
  44. 44.
    Shum L, Reeves SA, Kuo AC et al. Association of the transmembrane TGFα precursor with a protein kinase complex. J Cell Biol 1994; 125:903–916.PubMedCrossRefGoogle Scholar
  45. 45.
    Wells A. Molecules in focus. EGF receptor. Int J Biochem Cell Biol 1999; 31:637–643.PubMedCrossRefGoogle Scholar
  46. 46.
    Lin SY, Makino K, Xia W et al. Nuclear localization of EGF receptor and its potential new role as a transcription factor: Nature Cel Bio 2001; 3:802–808.CrossRefGoogle Scholar
  47. 47.
    Sadler GP, Morgan JM, Jasani B et al. Epidermal growth factor receptor status in hyperparathyroidism: Immunocytochemical and in situ hybridization study. World J Surg 1996; 20:736–743.PubMedCrossRefGoogle Scholar
  48. 48.
    Studer H, Derwahl M. Mechanisms of noneoplastic endocrine hyperplasia-A changing concept: A review focused on the thyroid gland: Endocrin Rev 1995; 16:411426.CrossRefGoogle Scholar
  49. 49.
    Kremer R, Bolivar I, Goltzman D et al. Influence of calcium and 1,25-dihydroxycholecalciferol on proliferation and proto-oncogene expression in primary cultures of bovine parathyroid cells. Endocrinology 1989; 125(2):935–941.PubMedCrossRefGoogle Scholar
  50. 50.
    Szabo A, Merke J, Beier E et al. 1,25(OH)2 vitamin D3 inhibits parathyroid cell proliferation in experimental uremia. Kidney Int 1989; 35:1049–1056.PubMedGoogle Scholar
  51. 51.
    Cozzolino M, Lu Y, Finch JL et al. p21 waf1 and TGFα mediate parathyroid growth arrest by vitamin D and high calcium. Kidney Intern 2001; 60:2109–2117.CrossRefGoogle Scholar
  52. 52.
    Tokumoto M, Hirakawa M, Tsuruya K et al. Diminished expressions of cyclin-dependent kinase inhibitor p21 and vitamin D receptor in nodular hyperplasia and in secondary hyperparathyroidism. J Am Soc Nephrol 2000; 11:584A.Google Scholar
  53. 53.
    Tong WM, Kallay E, Hofer H et al. Growth regulation of human cancer cells by epidermal growth factor and 1,25-dihydroxyvitamin D3 is mediated by mutual modulation of receptor expression: Eur J Cancer 1998; 34:2119–2125.PubMedCrossRefGoogle Scholar
  54. 54.
    Taoka T, Collins ED, Irino S et al. 1,25-(OH)2-vitamin D3 mediated changes in mRNA for c-myc and 1,25-(OH)2D3 receptor in HL60 cells and related subclones. Mol Cell Endocrinol 1993; 95:51–57.PubMedCrossRefGoogle Scholar
  55. 55.
    Simpson RU, Hsu T, Wendt MD et al. 1,25-dihydroxyvitamin D3 regulation of c-myc protooncogene transcription. Possible involvement of protein kinase C. J Biol Chem 1989; 264:19710–19715.PubMedGoogle Scholar
  56. 56.
    Grandis JR, Chakraborty A, Zeng Q et al. Downmodulation of TGFα protein expression with antisense oligonucleotides inhibits proliferation of head and neck squamous carcinoma but not normal mucosal epithelial cells. J Cell Biochem 1998; 69:55–62.PubMedCrossRefGoogle Scholar
  57. 57.
    Tong WM, Hofer H, Ellinger A et al. Mechanism of antimitogenic action of vitamin D in human colon carcinoma cells: Relevance for suppression of epidermal growth factor stimulated cell growth: Oncol Res 1999; 11:77–84.PubMedGoogle Scholar
  58. 58.
    Sheinin Y, Kaserer, Wrba F et al. In situ mRNA hybridization analysis and immunolocalization of the vitamin D receptor in normal and carcinomatous human colonic mucosa: relation to epidermal growth factor receptor expression: Virchows Arch 2000; 437:501–507.PubMedCrossRefGoogle Scholar
  59. 59.
    Jensen SS, Madsen MW, Lukas J et al. Inhibitory effects of 1,25-dihydroxyvitamin D3 on the G1-S phase-controlling machinery. Mol Endocrinol 2001; 15:1370–1380.PubMedCrossRefGoogle Scholar
  60. 60.
    Ritter C, Lu Y, Finch JL et al. 19-Nor-1,25 (OH)2D2 (19-Nor), an analog of calcitriol, suppresses parathyroid gland growth in uremic rats with established secondary hyperparathyroidism: J Am Soc Nephrol 2000; 11:581 A.Google Scholar
  61. 61.
    Nakagawa K, Kurobe M, Konno K et al. Structure-specific control of differentiation and apoptosis of human promyelocytic leukemia (HL-60) cells by A-ring diasteroisomers of 2-methyl-l, 25-dihydroxyvitamin D3 and its 20-epimer: Biochem Pharmacol 2000; 60:1937–1947.PubMedCrossRefGoogle Scholar
  62. 62.
    Amling M, Priemel M, Holzmann T et al. Rescue of the skeletal phenotype of vitamin D receptor-ablated mice in the setting of normal mineral ion homeostasis: formal histomorphometric and biochemical analyses. Endocrinology 1999; 140:4982–4987.PubMedCrossRefGoogle Scholar
  63. 63.
    Motellon JL, Jimenez FJ, de Miguel F et al. Relationship of plasma bone cytokines with hypercalcemia in cancer patients. Clin Chim Acta 2000; 302:59–68.PubMedCrossRefGoogle Scholar

Copyright information

© and Kluwer Academic / Plenum Publishers 2005

Authors and Affiliations

  • Adriana S. Dusso
    • 1
  • Mario Cozzolino
    • 1
  • Eduardo Slatopolsky
    • 1
  1. 1.Renal DivisionWashington University School of MedicineSt. LouisUSA

Personalised recommendations